jayinsat

I just answered this question. My Score PASS  

ISBT has an excellent podcast I have been listening too. You can listen and subscribe here:https://www.isbtweb.org/resource/announcing-our-new-podcast-transfusion-practitioners-across-the-world.html

This looks like a typical reaction due to an antibody against a low frequency antigen (like anti-Dia). This is how they are usually found. If you have the ability, I would run a selected cell panel on the pre and post using panel cells that are positive for Dia, co, V, LuA, KpA, etc. If not, send it to your reference lab to identify the antibody against the low frequency antigen. In the meantime, as you have already done, all xm's should be AHG.

Same. Are you doing both DAT Automation and DAT manual survey's?

Wow. Ortho does not produce their own qc material for antigen typing? We use the ECHO Lumena and the WBcorQC make that such a simple process. I'm surprised Ortho does not make their own. Now, if we can just get CAP to produce their RBCAT proficiency testing vials so we can run them on the ECHO's. That would be great!

Our window opens in October. I will not budge! If our inspector gives a deficiency for this item I will take my fight to CAP. If I do not win, then I will make the change. I am hoping by then they get their collective heads out of their posterior waste removal orifices and accept the rational and logical process.

I have had the exact same concern for years now. This is a strange position to be in, especially if you are a manager who regularly works the bench.

I worked at a site that sent cards. Never did any good. For all the work there was no benefit. As for the chip...pass.

I agree with Malcolm. I would dig as deep as possible to find that antibody history. If none can be found, I would do AHG crossmatches. If it was a frequent antibody, the titers should rise to detectable levels soon.

Can you give a little background on this? I am curious as to what this is.

I agree. CAP had a HIPPA compliant process for this during COVID and it was a PITA (see if you can figure out that acronym ). Outside of that, I would inform them that all those records would be available upon their arrival.

Lol. Do you have a validation guide and procedure for that?

There is one danger in this process, and I have seen it happen. Miscommunication between shifts opens the possibility of an expired unit being successfully issued because the expiration date in the LIS is different then what is manually written on the unit. If you are not changing the expiration in the LIS, you will need some sort of system in place (in policy and practice) that shows you mitigate this possibility.

I am not sure I understand your question. If the mother had an admission type and screen and was rh negative, then all that would be required post-delivery is the fetal bleed screen. Why would you want to repeat and antibody screen post delivery?

You are in a tough situation. Either your facility will need to invest in a digitrax printer to print ISBT labels or you should not modify the component in the LIS, only manually change the expiration date on the face label and document the new expiration after issue and transfusion (or by comment). I do not like the former option. I would insist on obtaining an ISBT label printer if I were in your position. That is the cost of having a blood bank.